|
| n = 36 |
| Age (year) | 50.8 ± 19.0 |
| Age range (year) | 19 - 82 |
| Diagnosis age (year) | 43.4 ± 17.2 |
| Sex |
|
| Male | 25 (69.4%) |
| Female | 11 (30.6%) |
| Diagnosis length (year) | 6 (1 - 20) |
| Family history | 29 (80.5%) |
| Accompanying disease |
|
| HT | 27 (75.0%) |
| CKD | 21 (58.3) |
| Liver Cyst | 23 (63.9%) |
| Intracranial aneurysm | 1 (%2.8) |
| Valve disease | 6 (16.7%) |
| CAH | 5 (13.9%) |
| LVH | 18 (50%) |
| DM | 5 (13.9%) |
| Nephrolithiasis | 8 (22.2%) |
| Macroscopic hematuria | 6 (16.7%) |
| Proteinuria | 11 (30.6%) |
| CKD length (year) | 6 (3 - 15) |
| Hemodialysis | 7 (19.4%) |
| Renal transplantation | 3 (8.3%) |
| Antihypertensive medication used |
|
| ARB | 9 (25%) |
| ACE-I | 8 (22.2%) |
| ARB + Calcium channel blocker | 4 (11.1%) |
| ARB + Beta blocker | 2 (5.6%) |
| ACE-I + Calcium Channel blocker | 3 (8.3%) |
| ACE-I + Beta blocker | 1 (2.8%) |
| None | 9 (25.0%) |